Market Blog

Positive sentiments for Bluebird Bio and VMWare

BLUE – Bluebird Bio Inc is focused on developing and commercializing drugs based on gene therapy to treat patients with genetic diseases and cancer. BLUE – Bluebird Bio Inc Fundamentals Previously closed at 47.72 Day's high 51.46 Day's low 47.61 P/E ratio NA EPS -2.44   Analysts opinion Bluebird Bio announced that its ongoing phase 2 study evaluating the product candidate “Lenti-D” for the treatment of cerebral adrenoleukodystrophy (CALD) will